Suppr超能文献

组织型纤溶酶原激活剂激活血小板衍生生长因子CC会损害缺血性中风期间的血脑屏障完整性。

Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke.

作者信息

Su Enming J, Fredriksson Linda, Geyer Melissa, Folestad Erika, Cale Jacqueline, Andrae Johanna, Gao Yamei, Pietras Kristian, Mann Kris, Yepes Manuel, Strickland Dudley K, Betsholtz Christer, Eriksson Ulf, Lawrence Daniel A

机构信息

Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor Michigan 48109-0644, USA.

出版信息

Nat Med. 2008 Jul;14(7):731-7. doi: 10.1038/nm1787. Epub 2008 Jun 22.

Abstract

Thrombolytic treatment of ischemic stroke with tissue plasminogen activator (tPA) is markedly limited owing to concerns about hemorrhagic complications and the requirement that tPA be administered within 3 h of symptoms. Here we report that tPA activation of latent platelet-derived growth factor-CC (PDGF-CC) may explain these limitations. Intraventricular injection of tPA or active PDGF-CC, in the absence of ischemia, leads to significant increases in cerebrovascular permeability. In contrast, co-injection of neutralizing antibodies to PDGF-CC with tPA blocks this increased permeability, indicating that PDGF-CC is a downstream substrate of tPA within the neurovascular unit. These effects are mediated through activation of PDGF-alpha receptors (PDGFR-alpha) on perivascular astrocytes, and treatment of mice with the PDGFR-alpha antagonist imatinib after ischemic stroke reduces both cerebrovascular permeability and hemorrhagic complications associated with late administration of thrombolytic tPA. These data demonstrate that PDGF signaling regulates blood-brain barrier permeability and suggest potential new strategies for stroke treatment.

摘要

由于对出血性并发症的担忧以及要求在症状出现后3小时内给予组织型纤溶酶原激活剂(tPA),缺血性中风的tPA溶栓治疗受到明显限制。在此我们报告,tPA激活潜在的血小板衍生生长因子CC(PDGF-CC)可能解释了这些限制。在无缺血的情况下,脑室内注射tPA或活性PDGF-CC会导致脑血管通透性显著增加。相反,将抗PDGF-CC中和抗体与tPA共同注射可阻断这种通透性增加,表明PDGF-CC是神经血管单元内tPA的下游底物。这些效应是通过激活血管周围星形胶质细胞上的血小板衍生生长因子α受体(PDGFR-α)介导的,缺血性中风后用PDGFR-α拮抗剂伊马替尼治疗小鼠可降低与溶栓tPA延迟给药相关的脑血管通透性和出血性并发症。这些数据表明,PDGF信号传导调节血脑屏障通透性,并提示了中风治疗的潜在新策略。

相似文献

2
Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
Acta Neuropathol. 2017 Oct;134(4):585-604. doi: 10.1007/s00401-017-1749-z. Epub 2017 Jul 19.
5
Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator.
J Biol Chem. 2005 Jul 22;280(29):26856-62. doi: 10.1074/jbc.M503388200. Epub 2005 May 23.
6
Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.
Biochim Biophys Acta. 2014 Feb;1842(2):318-25. doi: 10.1016/j.bbadis.2013.11.013. Epub 2013 Nov 19.
9
Tissue plasminogen activator is a potent activator of PDGF-CC.
EMBO J. 2004 Oct 1;23(19):3793-802. doi: 10.1038/sj.emboj.7600397. Epub 2004 Sep 16.
10
Tissue plasminogen activator-mediated PDGF signaling and neurovascular coupling in stroke.
J Thromb Haemost. 2009 Jul;7 Suppl 1(Suppl 1):155-8. doi: 10.1111/j.1538-7836.2009.03402.x.

引用本文的文献

1
Micrometer-scale tPA beads amplify plasmin generation for enhanced thrombolytic therapy.
Bioeng Transl Med. 2025 Mar 3;10(4):e70012. doi: 10.1002/btm2.70012. eCollection 2025 Jul.
2
Different roles of astrocytes in the blood-brain barrier during the acute and recovery phases of stroke.
Neural Regen Res. 2026 Apr 1;21(4):1359-1372. doi: 10.4103/NRR.NRR-D-24-01417. Epub 2025 Jun 19.
3
Efficacy and safety of imatinib in patients with COVID-19: a systematic review and meta-analysis.
Wien Klin Wochenschr. 2025 Jun 19. doi: 10.1007/s00508-025-02552-4.
4
Matrix metalloproteinase‑9 in hemorrhagic transformation after acute ischemic stroke (Review).
Mol Med Rep. 2025 Aug;32(2). doi: 10.3892/mmr.2025.13590. Epub 2025 Jun 6.
5
Bright Semiconductor Quantum Dots Shed New Light on Precision Nanomedicine for Various Diseases.
Small Sci. 2023 Nov 27;4(1):2300081. doi: 10.1002/smsc.202300081. eCollection 2024 Jan.
6
PA System in the Pathogenesis of Ischemic Stroke.
Arterioscler Thromb Vasc Biol. 2025 May;45(5):600-608. doi: 10.1161/ATVBAHA.125.322422. Epub 2025 Mar 27.
7
Imatinib on target in stroke recovery.
J Clin Invest. 2025 Mar 3;135(5):e190024. doi: 10.1172/JCI190024.
8
MgSO as a novel hypothermia infusion solution promotes ischemic stroke recovery through Ca regulation of neurovascular units.
Theranostics. 2025 Jan 2;15(5):1896-1913. doi: 10.7150/thno.104879. eCollection 2025.

本文引用的文献

7
Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator.
J Biol Chem. 2005 Jul 22;280(29):26856-62. doi: 10.1074/jbc.M503388200. Epub 2005 May 23.
8
Tissue plasminogen activator in central nervous system physiology and pathology.
Thromb Haemost. 2005 Apr;93(4):655-60. doi: 10.1160/TH04-12-0838.
10
Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors.
Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):443-8. doi: 10.1073/pnas.0406454102. Epub 2005 Jan 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验